DENISON MINES CORP. Logo

DENISON MINES CORP.

Uranium exploration and development company advancing projects in Canada's Athabasca Basin.

DNN | NYSE

Overview

Corporate Details

ISIN(s):
CA2483561072 (+1 more)
LEI:
Country:
United States of America
Address:
40 UNIVERSITY AVE., SUITE 1100, TORONTO
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Denison Mines Corp. is a uranium exploration and development company with its portfolio of interests concentrated in the Athabasca Basin region of northern Saskatchewan, Canada. The company's flagship asset is its 95% interest in the Wheeler River project, the largest undeveloped uranium project in the eastern Athabasca Basin. Denison's strategic assets also include a 22.5% interest in the McClean Lake mill, one of the world’s largest uranium processing facilities, and interests in other development-stage projects. The company is focused on advancing its key assets toward production, notably through the application of the In-Situ Recovery (ISR) mining method. Additionally, Denison holds a significant physical uranium inventory as a long-term investment to enhance future project financing.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all DENISON MINES CORP. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DENISON MINES CORP.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DENISON MINES CORP. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.
South Korea 187660
HYUNDAI BIOSCIENCE CO., LTD. Logo
Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.
South Korea 048410
iBio, Inc. Logo
AI-powered biotech developing antibody therapeutics for cardiometabolic diseases and obesity.
United States of America IBIO
Ibotta, Inc. Logo
A performance marketing platform offering cash-back rewards to consumers from CPG brands.
United States of America IBTA
ICON PLC Logo
Global CRO providing outsourced development & commercialization for pharma, biotech & device firms.
United States of America ICLR
IDEAYA Biosciences, Inc. Logo
Clinical-stage firm developing precision cancer therapies via synthetic lethality.
United States of America IDYA
IMGT Corporation Limited Logo
Develops a drug delivery platform using ultrasound and nanotech for oncology.
South Korea 456570
IMMERSION CORP Logo
Licenses patented haptic feedback technology for mobile, gaming, and automotive interfaces.
United States of America IMMR
IMMUNIC, INC. Logo
Developing oral small molecule therapies for chronic inflammatory and autoimmune diseases.
United States of America IMUX
IMMUTEP Ltd Logo
Developing LAG-3-based immunotherapies for cancer and autoimmune diseases.
United States of America IMMP

Talk to a Data Expert

Have a question? We'll get back to you promptly.